Role of leaflet modification in TAVI: to prevent coronary obstruction only or potentially a routine practice?
作者信息
Rogers Toby, Lupu Lior
机构信息
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, D.C., USA.
Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
出版信息
EuroIntervention. 2024 Jun 17;20(12):e733-e734. doi: 10.4244/EIJ-E-24-00029.
Abstract
摘要
相似文献
1
Role of leaflet modification in TAVI: to prevent coronary obstruction only or potentially a routine practice?瓣叶修整在经导管主动脉瓣置入术中的作用：仅是为了预防冠状动脉阻塞，还是可能成为一种常规操作？
EuroIntervention. 2024 Jun 17;20(12):e733-e734. doi: 10.4244/EIJ-E-24-00029.
2
Two-step approach to avoid obstruction of the coronary ostium during transcatheter aortic valve implantation with the SAPIEN 3.在使用SAPIEN 3进行经导管主动脉瓣植入术时避免冠状动脉口阻塞的两步法。
Cardiovasc Interv Ther. 2019 Jan;34(1):62-63. doi: 10.1007/s12928-017-0503-8. Epub 2017 Nov 25.
3
An alternative solution for patient with high risk of coronary obstruction underwent TAVI procedure using a novel second-generation device - a case series.对于冠状动脉阻塞高风险患者，采用新型第二代装置进行经导管主动脉瓣植入术（TAVI）的替代解决方案——病例系列
J Cardiothorac Surg. 2019 Feb 28;14(1):47. doi: 10.1186/s13019-019-0859-1.
4
Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience.在接受经导管主动脉瓣植入术的高危患者中预防冠状动脉阻塞：汉堡 BASILICA 经验。
Clin Res Cardiol. 2021 Dec;110(12):1900-1911. doi: 10.1007/s00392-021-01881-4. Epub 2021 Jun 22.
5
Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.经导管主动脉瓣植入术患者冠状动脉阻塞风险的瓣叶修饰：ShortCut 研究。
Eur Heart J. 2024 Sep 1;45(33):3031-3041. doi: 10.1093/eurheartj/ehae303.
6
Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.在外科生物人工主动脉瓣置换失败的瓣中瓣手术中，对有冠状动脉阻塞风险的患者进行瓣叶改良或烟囱支架置入术。
Catheter Cardiovasc Interv. 2023 Feb;101(3):655-659. doi: 10.1002/ccd.30561. Epub 2023 Jan 18.
7
First-in-Human Undermining Iatrogenic Coronary Obstruction With Radiofrequency Needle (UNICORN) Procedure During Valve-in-Valve Transcatheter Aortic Valve Replacement.在经导管主动脉瓣置换术的瓣中瓣手术中应用射频针进行首例人体医源性冠状动脉阻塞破坏（UNICORN）手术。
Circ Cardiovasc Interv. 2022 Nov;15(11):928-931. doi: 10.1161/CIRCINTERVENTIONS.122.012399. Epub 2022 Oct 21.
8
Leaflet modification with the ShortCut™ device to prevent coronary artery obstruction during TAVR.使用 ShortCut™ 装置对二尖瓣进行改良，以防止 TAVR 期间冠状动脉阻塞。
Cardiovasc Revasc Med. 2024 Aug;65:75-80. doi: 10.1016/j.carrev.2024.03.010. Epub 2024 Mar 18.
9
BASILICA Technique for Prevention of Coronary Artery Occlusion in High-Risk Native Transcatheter Aortic Valve Replacement.
Can J Cardiol. 2022 Aug;38(8):1312-1314. doi: 10.1016/j.cjca.2022.02.011. Epub 2022 Feb 16.
10
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation.经导管主动脉瓣植入术中减轻冠状动脉阻塞风险的瓣叶改良技术。
EuroIntervention. 2025 May 16;21(10):525-535. doi: 10.4244/EIJ-D-24-00972.
本文引用的文献
1
Impact of transcatheter heart valve type on outcomes of surgical explantation after failed transcatheter aortic valve replacement: the EXPLANT-TAVR international registry.经导管主动脉瓣置换术后失败行外科瓣置换术时不同经导管心脏瓣膜类型对结局的影响：EXPLANT-TAVR 国际注册研究。
EuroIntervention. 2024 Jan 15;20(2):e146-e157. doi: 10.4244/EIJ-D-23-00722.
2
Leaflet and Neoskirt Height in Transcatheter Heart Valves: Implications for Repeat Procedures and Coronary Access.经导管心脏瓣膜中叶瓣和新裙边高度：对重复手术及冠状动脉通路的影响
JACC Cardiovasc Interv. 2021 Oct 25;14(20):2298-2300. doi: 10.1016/j.jcin.2021.07.034. Epub 2021 Sep 29.
3
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.经皮主动脉瓣置换术后重复使用自膨式 Evolut 瓣膜的冠状动脉阻塞风险和冠状动脉入路的可行性：计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4.
4
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后窦房隔离致冠状动脉阻塞的风险。
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2617-2627. doi: 10.1016/j.jcin.2020.09.022.
5
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients.低危人群行 TAVR 患者的冠状动脉入路和主动脉瓣再介入的可行性。
JACC Cardiovasc Interv. 2020 Mar 23;13(6):726-735. doi: 10.1016/j.jcin.2020.01.202.
6
Coronary Artery Disease and Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.冠状动脉疾病与经导管主动脉瓣置换术：JACC 最新技术评论。
J Am Coll Cardiol. 2019 Jul 23;74(3):362-372. doi: 10.1016/j.jacc.2019.06.012.
7
Impact of Leaflet Laceration on Transcatheter Aortic Valve-in-Valve Washout: BASILICA to Solve Neosinus and Sinus Stasis.瓣叶裂伤对经导管主动脉瓣中瓣瓣周漏反流的影响：BASILICA 研究解决新窦和窦部淤滞
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1229-1237. doi: 10.1016/j.jcin.2019.04.013.
8
The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.BASILICA 试验：旨在通过主动撕裂瓣叶预防 TAVR 冠状动脉阻塞的前瞻性多中心研究。
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1240-1252. doi: 10.1016/j.jcin.2019.03.035. Epub 2019 Jun 12.
Zotero 插件